Skip to main content

Table 1 Clinical pathological characteristics correlation analysis with MUC1-C expression in a 131 NSCLC cohort

From: Evodiamine suppresses non-small cell lung cancer by elevating CD8+ T cells and downregulating the MUC1-C/PD-L1 axis

Characteristics Total MUC1-C expression F/X2 P-value
Negative (%) Low (%) High (%)
Age (years)      0.776 0.678
 < =65 105 7 (6.7) 32 (30.5) 66 (62.9)   
 > 65 26 1 (3.8) 10 (38.5) 15 (57.7)   
Gender      16.215 < 0.001
 Male 105 8 (7.6) 41 (39.0) 56 (53.3)   
 Female 26 0 (0.0) 1 (3.8) 25 (96.2)   
Smoking history      17.501 < 0.001
 Yes 90 8 (8.9) 37 (41.1) 45 (50.0)   
 No 41 0 (0.0) 5 (12.2) 36 (87.8)   
Pathological pattern      60.153 < 0.001
 Adenocarcinoma 74 0 (0.0) 7 (9.5) 67 (90.5)   
 Squamous cell 57 8 (14.0) 35 (61.4) 14 (24.6)   
Cell differentiation      5.542 0.236
 Poorly 28 1 (3.6) 12 (42.9) 15 (53.6)   
 Moderately 93 5 (5.4) 28 (30.1) 60 (64.5)   
 Well 10 2 (20.0) 2 (20.0) 6 (60.0)   
TNM stage      13.306 0.038
 I 62 4 (6.5) 18 (29.0) 40 (64.5)   
 II 37 3 (8.1) 19 (51.4) 15 (40.5)   
 III 28 1 (3.6) 5 (17.9) 22 (78.6)   
 IV 4 0 (0.0) 0 (0.0) 4 (100.0)